MacroGenics
MGNX
#8252
Rank
S$0.35 B
Marketcap
S$5.54
Share price
-4.31%
Change (1 day)
189.53%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): S-$0.09250

According to MacroGenics's latest financial reports the company's current EPS (TTM) is S-$0.06386. In 2024 the company made an earnings per share (EPS) of S-$1.37 a decrease over its 2023 EPS that were of S-$0.19.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.09250-93.23%
2024S-$1.37613.33%
2023S-$0.19-92.31%
2022S-$2.49-42.14%
2021S-$4.3036.44%
2020S-$3.15-21.84%
2019S-$4.04-24.58%
2018S-$5.35675.93%
2017S-$0.69-68.05%
2016S-$2.16168.25%
2015S-$0.80-55%
2014S-$1.793400%
2013S-$0.05109-108.68%
2012S$0.5924.49%
2011S$0.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.67-2,720.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.05-56,550.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.49-29,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$8.75-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.54-7,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.55-7,220.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S-$2.26 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA